Athira Pharma, Inc.
ATHA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Market Cap | $22,588 | $92,389 | $119,614 | $481,083 |
| - Cash | $48,438 | $90,584 | $95,966 | $110,537 |
| + Debt | $1,217 | $1,585 | $1,911 | $1,920 |
| Enterprise Value | -$24,633 | $3,390 | $25,559 | $372,466 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | -$479 |
| % Margin | – | – | – | – |
| EBITDA | -$95,805 | -$125,968 | -$88,010 | -$54,371 |
| % Margin | – | – | – | – |
| Net Income | -$96,940 | -$117,672 | -$95,639 | -$54,853 |
| % Margin | – | – | – | – |
| EPS Diluted | -25.2 | -30.9 | -25.3 | -14.9 |
| % Growth | 18.4% | -22.1% | -69.8% | – |
| Operating Cash Flow | -$97,170 | -$100,753 | -$72,469 | -$43,098 |
| Capital Expenditures | -$33 | -$304 | -$1,141 | -$1,573 |
| Free Cash Flow | -$97,203 | -$101,057 | -$73,610 | -$44,671 |